Labshake search
Citations for Tocris :
1 - 50 of 707 citations for 7 Benzothiazolethiol 6 amino 2 methyl 9CI since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2020Quote: MPEP (2-Methyl-6-(phenylethynyl)pyridine) from Tocris
-
bioRxiv - Neuroscience 2023Quote: ... (S)-2-Amino-2-methyl-4-phosphonobutanoic acid (MAP4; 250 µM; Tocris, Item# 0711), Tetrodotoxin (TTX ...
-
bioRxiv - Neuroscience 2020Quote: ... (S)-1-(2-Amino-2-carboxyethyl)-3-(2-carboxy-5-phenylthiophene-3-yl-methyl)-5-methylpyrimidine-2,4-dione (ACET; 1μM; Tocris Bioscience, catalog #2728).
-
bioRxiv - Neuroscience 2023Quote: ... P3029) and 2-methyl-6-(phenylethynyl)pyridine (MPEP; Tocris, Ellisville, MO, Cat. No. 1212/10), solutions were made fresh in sterile saline before use ...
-
bioRxiv - Neuroscience 2020Quote: ... JNJ16259685 and 2-Methyl-6-(phenylethynyl)pyridine (MPEP) hydrochloride were purchased from Tocris (Minneapolis MN, USA). (±)-Sulpiride was purchased from MilliporeSigma ...
-
bioRxiv - Neuroscience 2023Quote: ... in the presence of the mGluR5 antagonist 2-methyl-6 (phenylethynyl)-pyridine (MPEP, 25 μM; Tocris Bioscience) in ACSF at 31-33°C as previously (18) ...
-
bioRxiv - Pharmacology and Toxicology 2023Quote: ... 2-[[6-amino-3,5-dicyano-4-[4-(cyclopropylmethoxy) phenyl]-2-pyridinyl]thio]-acetamide (BAY 60-6583; Tocris, 910487-58-0), 1-[2-chloro-6-[[(3-iodophenyl)methyl]amino]-9H-purin-9-yl]-1-deoxy-N-methyl-β-D-ribofuranuronamide (2-Chloro-IB-MECA ...
-
bioRxiv - Cancer Biology 2022Quote: ... the small molecule 3-[2-[(4-Fluorophenyl)methyl]imidazo[2,1-b]thiazol-6-yl]-2H-1-benzopyran-2-one (iMDK; TOCRIS Bio-techne, 9mg/kg), rapamycin (Sirolimus A8167 ...
-
bioRxiv - Neuroscience 2019Quote: ... in the presence of the mGluR5 antagonist 2-methyl-6 (phenylethynyl)-pyridine (MPEP, 25 μM; Tocris Bioscience, Bristol, UK). Inhibitors were applied concomitantly from 30 min before to 30 min after DHPG/MPEP treatment ...
-
bioRxiv - Neuroscience 2021Quote: ... The mGluR5 specific negative allosteric modulator MPEP hydrochloride (2-Methyl-6-(phenylethynyl)pyridine hydrochloride) was purchased from Tocris (1212) and administered to brain slices at 30 μM by bath perfusion ...
-
bioRxiv - Microbiology 2022Quote: ... 3 μl of 10 mM of NBD-(linezolid-7-nitrobenz-2-oxa-1,3-diazol-4-yl)-amino-D-alanine (NADA) (Tocris Bioscience) was added to the resuspension ...
-
bioRxiv - Microbiology 2023Quote: ... cells were resuspended in 25 µl PBS together with 0.25 µl of 5 mM 3-[[(7-Hydroxy-2-oxo-2H-1-benzopyran-3-yl) carbonyl]amino]-D-alanine hydrocholoride (HADA) (Tocris) dissolved in DMSO ...
-
bioRxiv - Molecular Biology 2019Quote: ... 2-methyl-ADP (Tocris, Bristol, UK # 475193-31-8), U46619 (Cayman Chemical # 56985-40-1) ...
-
bioRxiv - Neuroscience 2020Quote: ... 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX, Tocris), 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo[f]quinoxaline-2,3-dione (NBQX ...
-
bioRxiv - Neuroscience 2022Quote: ... containing 10 μM 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) and 50 μM D,L-2-amino-5-phosphonovaleric acid (AP5) (both from Tocris, Bristol, UK) to block recurrent glutamatergic signaling.
-
bioRxiv - Cell Biology 2020Quote: ... 2-(4-chlorophenyl)-3-methyl-N-(thiazole-2-yl)butanamide (4-CMTB; Tocris) was used as a FFAR2-specific agonist and AR420626 (Cayman ...
-
bioRxiv - Cell Biology 2019Quote: ... 10µM 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX; Tocris), and 50µM D-(-)-2-amino-5-phosphonopentanoic (D-AP5 or APV ...
-
bioRxiv - Neuroscience 2022Quote: ... 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX, TOCRIS bioscience #0190), D,L-2-amino-5-phosphonovaleric acid (AP5 ...
-
bioRxiv - Neuroscience 2019Quote: ... D- (-)-2-Amino-5-phosphonopentanoic acid (D-AP5, Tocris) and STR were added to the bath solution to block AMPA ...
-
bioRxiv - Cell Biology 2021Quote: ... L-2-amino-5-phosphonovaleric acid (AP5, Tocris Bioscience) were included in the bath solution to prevent recurrent activities.
-
bioRxiv - Neuroscience 2022Quote: ... and d-(−)-2-amino-5-phosphonopentanoic acid (APV, Tocris) were added to the ACSF ...
-
bioRxiv - Neuroscience 2024Quote: ... D-(-)-2-Amino-5-phosphonopentanoic acid (D-AP5, Tocris), tetrodotoxin (TTX ...
-
bioRxiv - Cell Biology 2021Quote: ... 20 μM 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX, Tocris Bioscience) and 50 μM D ...
-
bioRxiv - Neuroscience 2019Quote: ... 50µM 6-Cyano-7-nitroquinoxaline-2,3-dione disodium salt (CNQX, Tocris), 200µM D-(-)-2-Amino-5-phosphonopentanoic acid (D-AP5 ...
-
bioRxiv - Neuroscience 2021Quote: ... 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX; 10 µM, Tocris, UK), DL-2-Amino-5-phosphonopentanoic acid (DL-AP5 ...
-
bioRxiv - Physiology 2024Quote: ... N-(3-aminopropyl)-2-{[(3-methylphenyl)methyl]oxy}-N-(2-thienylmethyl)benzamide hydrochloride salt (AMTB, Tocris #3989) 10 mM in H2O ...
-
bioRxiv - Microbiology 2022Quote: NADA (3-[(7-Nitro-2,1,3-benzoxadiazol-4-yl)amino]-D-alanine hydrochloride) was synthesized by Tocris following the published protocol (31) ...
-
bioRxiv - Cell Biology 2021Quote: ... Calcium-like peptide 2 (CALP2) and N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide hydrochloride (W-7) were obtained from Tocris (Minneapolis, MN). CaM kinase II and calcineurin inhibitors ...
-
bioRxiv - Neuroscience 2020Quote: ... and D-2-amino-5-phosphonovalerate (APV, 25 µM, Tocris) in order to block synaptic transmission and ensure that the observed events were due to the stimulation only ...
-
bioRxiv - Neuroscience 2022Quote: ... 50 D-2-amino-5-phosphonopentanoic acid (D-APV) (Tocris), and 10 gabazine (Sigma) ...
-
bioRxiv - Neuroscience 2020Quote: ... and D(-)-2-Amino-5-phosphonopentanoic acid (D-AP5, Tocris) was prepared as 50 mM stocks dissolved in 30% 1 M NaOH ...
-
bioRxiv - Neuroscience 2020Quote: ... DL-2-Amino-5-phosphonopentanoic acid (APV, 50 μM, Tocris) was added to the ACSF to avoid the unintended N-methyl-D-aspartate receptor (NMDAR ...
-
bioRxiv - Neuroscience 2019Quote: ... 200µM D-(-)-2-Amino-5-phosphonopentanoic acid (D-AP5, Tocris). All these compounds were applied in the recording chamber for at least 10 minutes before continuing measurements ...
-
bioRxiv - Neuroscience 2021Quote: ... and d-2-amino-5-phosphonopentanoic acid (D-AP5) (Tocris). Drugs were prepared as concentrated stock solutions and were diluted in ACSF on the day of the experiment.
-
bioRxiv - Neuroscience 2021Quote: ... 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX disodium salt, Catalog #1045, Tocris), (R)-Baclofen (Catalog #0796 ...
-
bioRxiv - Neuroscience 2019Quote: ... 20 µM 7-nitro-2,3-dioxo-1,4-dihydroquinoxaline-6-carbonitrile (CNQX; Tocris), and 50 µM D-2-amino-5-phosphonovaleric acid (D-AP-5 ...
-
bioRxiv - Cell Biology 2021Quote: ... at 50 μM and 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX, Tocris) at 20 μM in the bath solution to block excitatory synaptic transmission ...
-
bioRxiv - Neuroscience 2020Quote: ... and CNQX (6-cyano-7-nitroquinoxaline-2,3-dione) were purchased from TOCRIS Bioscience (Cat ...
-
bioRxiv - Neuroscience 2022Quote: ... 2,3-dioxo-6-nitro-7-sulfamoyl-benzoquinoxaline (NBQX, 25 μM; Tocris #0373), D-2-Amino-5-phosphonopentanoic acid (D-AP5 ...
-
bioRxiv - Immunology 2022Quote: ... BV-6 and Birinapant (from SelleckChem) and (5Z)-7-Oxozeaenol (from Tocris) were dissolved in DMSO at 10 mM and added to achieve the final concentrations indicated in figure legends ...
-
bioRxiv - Neuroscience 2022Quote: ... 6-cyano-7-nitroquinoxaline-2,3-dione disodium (CNQX, Tocris, Minneapolis, MN, USA) and d-(−)-2-amino-5-phosphonopentanoic acid (APV ...
-
bioRxiv - Neuroscience 2022Quote: ... 10 μM 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX, TOCRIS bioscience #0190), and 50 μM D,L-2-amino-5-phosphonovaleric acid (AP5 ...
-
bioRxiv - Neuroscience 2020Quote: ... co-applied with the competitive α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid AMPA/kainate receptor antagonist CNQX (Tocris; 20 μM) (n=13) ...
-
bioRxiv - Neuroscience 2022Quote: ... 3,5-dichloro-N-[[(1α,5α,6-exo,6α)-3-(3,3-dimethylbutyl)-3-azabicyclo[3.1.0]hex-6-yl]methyl]-benzamide-hydrochloride (ML218 or ml) was purchased from TOCRIS and initially dissolved at 50 mM in DMSO ...
-
bioRxiv - Neuroscience 2020Quote: ... 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo[f]quinoxaline-2,3-dione (NBQX, Tocris) and N,N,H,-Trimethyl-5-[(tricyclo[3.3.1.13,7]dec-1-ylmethyl)amino]-1-pentanaminiumbromide hydrobromide (IEM-1460 ...
-
bioRxiv - Neuroscience 2020Quote: NBQX (2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide) from Tocris CGP-55845 ((2S)-3-[[(1S)-1-(3,4-Dichlorophenyl)ethyl]amino-2-hydro xypropyl](phenylmethyl)phosphinic acid hydrochloride ...
-
bioRxiv - Neuroscience 2023Quote: ... Inhibitor cocktail containing 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX; Tocris, 10 μM), (2R)-2-amino-5-phosphonopentanoic acid (AP5 ...
-
bioRxiv - Neuroscience 2024Quote: ... 2,3-dioxo-6-nitro-7-sulfamoyl-benzo[f]quinoxaline (NBQX, 10 μM; Tocris), and D-2-amino-5-phosphonopetanoate (D-AP5 ...
-
bioRxiv - Neuroscience 2021Quote: ... and 40 µM D(−)-2-amino-5-phosphonovaleric acid (APV; Tocris) and 50 nM of rat CGRP or vehicle ...
-
bioRxiv - Neuroscience 2021Quote: ... DL-2-Amino-5-phosphonopentanoic acid (DL-AP5, 40 µM, Tocris), bicuculline methiodide (Bic ...